153 related articles for article (PubMed ID: 28814137)
1. PEGylated crosslinked hyaluronic acid nanoparticles designed through a microfluidic platform for nanomedicine.
Russo M; Grimaldi AM; Bevilacqua P; Tammaro O; Netti PA; Torino E
Nanomedicine (Lond); 2017 Sep; 12(18):2211-2222. PubMed ID: 28814137
[TBL] [Abstract][Full Text] [Related]
2. A Microfluidic Platform to design crosslinked Hyaluronic Acid Nanoparticles (cHANPs) for enhanced MRI.
Russo M; Bevilacqua P; Netti PA; Torino E
Sci Rep; 2016 Nov; 6():37906. PubMed ID: 27901092
[TBL] [Abstract][Full Text] [Related]
3. Commentary on "A Microfluidic Platform to Design Crosslinked Hyaluronic Acid Nanoparticles (cHANPs) for Enhanced MRI".
Russo M; Bevilacqua P; Netti PA; Torino E
Mol Imaging; 2017 Jan; 16():1536012117706237. PubMed ID: 28654388
[TBL] [Abstract][Full Text] [Related]
4. Hydrodenticity to enhance relaxivity of gadolinium-DTPA within crosslinked hyaluronic acid nanoparticles.
Russo M; Ponsiglione AM; Forte E; Netti PA; Torino E
Nanomedicine (Lond); 2017 Sep; 12(18):2199-2210. PubMed ID: 28816102
[TBL] [Abstract][Full Text] [Related]
5. A Microfluidic Platform to design Multimodal PEG - crosslinked Hyaluronic Acid Nanoparticles (PEG-cHANPs) for diagnostic applications.
Tammaro O; Costagliola di Polidoro A; Romano E; Netti PA; Torino E
Sci Rep; 2020 Apr; 10(1):6028. PubMed ID: 32265496
[TBL] [Abstract][Full Text] [Related]
6. PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo.
Choi KY; Min KH; Yoon HY; Kim K; Park JH; Kwon IC; Choi K; Jeong SY
Biomaterials; 2011 Mar; 32(7):1880-9. PubMed ID: 21159377
[TBL] [Abstract][Full Text] [Related]
7. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
[TBL] [Abstract][Full Text] [Related]
8. Albumin Based Nanoparticles for Detection of Pancreatic Cancer Cells.
Karaca N; Ünlüer ÖB
Protein Pept Lett; 2019; 26(4):271-280. PubMed ID: 30659529
[TBL] [Abstract][Full Text] [Related]
9. Core cross-linked poly(ethylene glycol)-graft-Dextran nanoparticles for reduction and pH dual responsive intracellular drug delivery.
Lian H; Du Y; Chen X; Duan L; Gao G; Xiao C; Zhuang X
J Colloid Interface Sci; 2017 Jun; 496():201-210. PubMed ID: 28232293
[TBL] [Abstract][Full Text] [Related]
10. A novel cross-linked nanoparticle with aggregation-induced emission properties for cancer cell imaging.
Li B; Chen T; Wang Z; Guo Z; Peña J; Zeng L; Xing J
J Mater Chem B; 2020 Mar; 8(12):2431-2437. PubMed ID: 32104870
[TBL] [Abstract][Full Text] [Related]
11. Enhanced colloidal stability and protein resistance of layered double hydroxide nanoparticles with phosphonic acid-terminated PEG coating for drug delivery.
Cao Z; Adnan NNM; Wang G; Rawal A; Shi B; Liu R; Liang K; Zhao L; Gooding JJ; Boyer C; Gu Z
J Colloid Interface Sci; 2018 Jul; 521():242-251. PubMed ID: 29574343
[TBL] [Abstract][Full Text] [Related]
12. Multifunctional pH-sensitive polymeric nanoparticles for theranostics evaluated experimentally in cancer.
Liu Y; Feng L; Liu T; Zhang L; Yao Y; Yu D; Wang L; Zhang N
Nanoscale; 2014 Mar; 6(6):3231-42. PubMed ID: 24500240
[TBL] [Abstract][Full Text] [Related]
13. Bioimaging of hyaluronic acid derivatives using nanosized carbon dots.
Goh EJ; Kim KS; Kim YR; Jung HS; Beack S; Kong WH; Scarcelli G; Yun SH; Hahn SK
Biomacromolecules; 2012 Aug; 13(8):2554-61. PubMed ID: 22804331
[TBL] [Abstract][Full Text] [Related]
14. Protein-Sized Bright Fluorogenic Nanoparticles Based on Cross-Linked Calixarene Micelles with Cyanine Corona.
Shulov I; Rodik RV; Arntz Y; Reisch A; Kalchenko VI; Klymchenko AS
Angew Chem Int Ed Engl; 2016 Dec; 55(51):15884-15888. PubMed ID: 27862803
[TBL] [Abstract][Full Text] [Related]
15. Cellular uptake and degradation behaviour of biodegradable poly(ethylene glycol-graft-methyl methacrylate) nanoparticles crosslinked with dimethacryloyl hydroxylamine.
Scheler S; Kitzan M; Fahr A
Int J Pharm; 2011 Jan; 403(1-2):207-18. PubMed ID: 20969936
[TBL] [Abstract][Full Text] [Related]
16. Upconverting rare-earth nanoparticles with a paramagnetic lanthanide complex shell for upconversion fluorescent and magnetic resonance dual-modality imaging.
Wang Y; Ji L; Zhang B; Yin P; Qiu Y; Song D; Zhou J; Li Q
Nanotechnology; 2013 May; 24(17):175101. PubMed ID: 23558298
[TBL] [Abstract][Full Text] [Related]
17. Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation.
Han X; Li Z; Sun J; Luo C; Li L; Liu Y; Du Y; Qiu S; Ai X; Wu C; Lian H; He Z
J Control Release; 2015 Jan; 197():29-40. PubMed ID: 25449802
[TBL] [Abstract][Full Text] [Related]
18. Microfluidic platform for combinatorial synthesis and optimization of targeted nanoparticles for cancer therapy.
Valencia PM; Pridgen EM; Rhee M; Langer R; Farokhzad OC; Karnik R
ACS Nano; 2013 Dec; 7(12):10671-80. PubMed ID: 24215426
[TBL] [Abstract][Full Text] [Related]
19. Intrinsically Mn2+-Chelated Polydopamine Nanoparticles for Simultaneous Magnetic Resonance Imaging and Photothermal Ablation of Cancer Cells.
Miao ZH; Wang H; Yang H; Li ZL; Zhen L; Xu CY
ACS Appl Mater Interfaces; 2015 Aug; 7(31):16946-52. PubMed ID: 26196160
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronic Acid Modified Tantalum Oxide Nanoparticles Conjugating Doxorubicin for Targeted Cancer Theranostics.
Jin Y; Ma X; Feng S; Liang X; Dai Z; Tian J; Yue X
Bioconjug Chem; 2015 Dec; 26(12):2530-41. PubMed ID: 26554699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
